{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:38:45Z","timestamp":1770536325446,"version":"3.49.0"},"reference-count":43,"publisher":"The Fukushima Society of Medical Science","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FJMS","Fukushima J. Med. Sci."],"published-print":{"date-parts":[[2020]]},"DOI":"10.5387\/fms.2020-07","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T22:07:12Z","timestamp":1604614032000},"page":"160-166","source":"Crossref","is-referenced-by-count":6,"title":["Familial Mediterranean fever phenotype progression into anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis:a case report"],"prefix":"10.5387","volume":"66","author":[{"given":"Toru","family":"Yago","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","unstructured":"1.  Doria A, Zen M, Bettio S, <i>et al.<\/i> Autoinflammation and autoimmunity:bridging the divide. Autoimmun Rev, <b>12<\/b>:22-30, 2012."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2.  Padeh S, Berkun Y. Familial Mediterranean fever. Curr Opin Rheumatol, <b>28<\/b>:523-529, 2016.","DOI":"10.1097\/BOR.0000000000000315"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3.  Jamilloux Y, Magnotti F, Belot A, Henry T. The pyrin inflammasome:from sensing RhoA GTPases-inhibiting toxins to triggering autoinflammatory syndromes. Pathog Dis, <b>76<\/b>: doi:10.1093\/femspd\/fty020, 2018.","DOI":"10.1093\/femspd\/fty020"},{"key":"4","unstructured":"4.  Migita K, Agematsu K, Yazaki M, <i>et al.<\/i> Familial Mediterranean fever:genotype-phenotype correlations in Japanese patients. Medicine (Baltimore), <b>93<\/b>:158-164, 2014."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5.  Migita K, Izumi Y, Jiuchi Y, <i>et al.<\/i> Familial Mediterranean fever is no longer a rare disease in Japan. Arthritis Res Ther, <b>18<\/b>:175, 2016.","DOI":"10.1186\/s13075-016-1071-5"},{"key":"6","unstructured":"6.  Aletaha D, Neogi T, Silman AJ, <i>et al.<\/i> 2010 Rheumatoid arthritis classification criteria:an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum, <b>62<\/b>:2569-2581, 2010."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7.  Livneh A, Langevitz P, Zemer D, <i>et al.<\/i> Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum, <b>40<\/b>:1879-1885, 1997.","DOI":"10.1002\/art.1780401023"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8.  El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs. Lancet, <b>367<\/b>:1016-1024, 2006.","DOI":"10.1016\/S0140-6736(06)68430-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9.  Migita K, Uehara R, Nakamura Y, <i>et al.<\/i> Familial Mediterranean fever in Japan. Medicine (Baltimore), <b>91<\/b>:337-343, 2012.","DOI":"10.1097\/MD.0b013e318277cf75"},{"key":"10","unstructured":"10.  Migita K, Asano T, Sato S, Koga T, Fujita Y, Kawakami A. Familial Mediterranean fever:  overview of pathogenesis, clinical features and management. Immunol Medicine, <b>41<\/b>:55-61, 2018."},{"key":"11","unstructured":"11.  Tunca M, Akar S, Onen F, <i>et al.<\/i> Familial Mediterranean fever (FMF) in Turkey:results of a nationwide multicenter study. Medicine, <b>84<\/b>:  1-11, 2005."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12.  Giancane G, Ter Haar NM, Wulffraat N, <i>et al.<\/i> Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis, <b>74<\/b>:635-641, 2015.","DOI":"10.1136\/annrheumdis-2014-206844"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13.  Hotta Y, Kawasaki T, Kotani T, <i>et al.<\/i> Familial Mediterranean Fever Without Fever. Intern Med, <b>59<\/b>:1267-1270, 2020.","DOI":"10.2169\/internalmedicine.3175-19"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14.  Iwata K, Toma T, Yachie A. 38-year-old woman with recurrent abdominal pain, but no fever. Int J Gen Med, <b>5<\/b>:265-268, 2012.","DOI":"10.2147\/IJGM.S30867"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15.  Mattiassich G, Semlitsch G, Nadler K, Rainer F. Familial Mediterranean fever without fever as a cause of monoarthritis. BMJ Case Rep, <b>4<\/b>: bcr2012008395, 2013.","DOI":"10.1136\/bcr-2012-008395"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16.  Blomqvist A, Engblom D. Neural Mechanisms of Inflammation-Induced Fever. Neuroscientist, <b>24<\/b>:381-399, 2018.","DOI":"10.1177\/1073858418760481"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17.  Karadag O, Tufan A, Yazisiz V, <i>et al.<\/i> The factors considered as trigger for the attacks in patients with familial Mediterranean fever. Rheumatol Int, <b>33<\/b>:893-897, 2013.","DOI":"10.1007\/s00296-012-2453-x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18.  French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet, <b>17<\/b>:25-31, 1997.","DOI":"10.1038\/ng0997-25"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19.  Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet, <b>9<\/b>:473-483, 2001.","DOI":"10.1038\/sj.ejhg.5200658"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20.  Shinar Y, Obici L, Aksentijevich I, <i>et al.<\/i> Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis, <b>71<\/b>:1599-1605, 2012.","DOI":"10.1136\/annrheumdis-2011-201271"},{"key":"21","unstructured":"21.  Migita K, Nakamura T, Maeda Y, <i>et al.<\/i> MEFV mutations in Japanese rheumatoid arthritis patients.  Clin Exp Rheumatol, <b>26<\/b>:1091-1094, 2008."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22.  Fujita Y, Asano T, Sato S, <i>et al.<\/i> Coexistence of mixed connective tissue disease and familial Mediterranean fever in a Japanese patient. Intern Med, <b>58<\/b>:2235-2240, 2019.","DOI":"10.2169\/internalmedicine.2376-18"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23.  Migita K, Abiru S, Sasaki O, <i>et al.<\/i> Coexistence of familial Mediterranean fever and rheumatoid arthritis. Mod Rheumatol, <b>24<\/b>:212-216, 2014.","DOI":"10.3109\/14397595.2013.852843"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24.  Uthman I, Hajj-Ali RA, Arayssi T, Masri AF, Nasr F. Arthritis in familial Mediterranean fever. Rheumatol Int, <b>20<\/b>:145-148, 2001.","DOI":"10.1007\/s002960100103"},{"key":"25","unstructured":"25.  Endo Y, Koga T, Ishida M, <i>et al.<\/i> Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever:  Data from a multicenter, prospective national chort study in Japan. Arthritis Res Ther, <b>20<\/b>:257, 2018."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26.  Nam JL, D\u2019Agostino MA. Role of ultrasound imaging in individuals at risk of RA. Best Pract Res Clin Rheumatol,<b> 31<\/b>:71-79, 2017.","DOI":"10.1016\/j.berh.2017.09.002"},{"key":"27","unstructured":"27.  Guler E, Kaptanoglu E, Sahin O, Candan F, Hayta E, Elden H. Autoantibodies are not associated with familial mediterranean fever. Acta Reumatol Port, <b>37<\/b>:144-148, 2012."},{"key":"28","unstructured":"28.  Ohmura K, Terao C, Maruya E, <i>et al.<\/i> Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset:a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis. Rheumatology (Oxford), <b>49<\/b>:2298-2304, 2010."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29.  Uyanik A, Albayrak F, Uyanik MH, Dursun H, Keles M, Cetinkaya R. Antibodies directed to cyclic citrullinated peptides in familial Mediterranean fever. Rheumatol Int, <b>30<\/b>:467-471, 2010.","DOI":"10.1007\/s00296-009-0993-5"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31.  Hedrich CM. Shaping the spectrum - From autoinflammation to autoimmunity. Clin Immunol, <b>165<\/b>:21-28, 2016.","DOI":"10.1016\/j.clim.2016.03.002"},{"key":"31","unstructured":"32.  Henderson C, Goldbach-Mansky R. Monogenic autoinflammatory diseases:new insights into clinical aspects and pathogenesis. Curr Opin Rheumatol, <b>22<\/b>:567-578, 2010."},{"key":"32","doi-asserted-by":"crossref","unstructured":"33.  Ombrello MJ, Remmers EF, Tachmazidou I, <i>et al.<\/i> HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci U S A, <b>112<\/b>:15970-15975, 2015.","DOI":"10.1186\/1546-0096-13-S1-O75"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34.  Kadowaki T, Ohnishi H, Kawamoto N, <i>et al.<\/i> Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders. J Allergy Clin Immunol, <b>141<\/b>:1485-1488, 2018.","DOI":"10.1016\/j.jaci.2017.10.039"},{"key":"34","unstructured":"35.  Croia C, Bursi R, Sutera D, Petrelli F, Alunno A, Puxeddu I. One year in review 2019:pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol, <b>37<\/b>:347-357, 2019."},{"key":"35","unstructured":"36.  de Torre-Minguela C, Mesa Del Castillo P, Pelegr\u00edn P. The NLRP3 and Pyrin Inflammasomes:  Implications in the pathophysiology of autoinflammatory diseases. Front Immunol, <b>8<\/b>:43, 2017."},{"key":"36","doi-asserted-by":"crossref","unstructured":"37.  So A, Ives A, Joosten LA, Busso N. Targeting inflammasomes in rheumatic diseases. Nat Rev Rheumatol, <b>9<\/b>:391-399, 2013.","DOI":"10.1038\/nrrheum.2013.61"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38.  Xu H, Yang J, Gao W, <i>et al.<\/i> Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature, <b>513<\/b>:237-241, 2014.","DOI":"10.1038\/nature13449"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39.  Gao W, Yang J, Liu W, Wang Y, Shao F. Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation. Proc Natl Acad Sci U S A, <b>113<\/b>:E4857-E4866, 2016.","DOI":"10.1073\/pnas.1601700113"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40.  Rescigno M. Intestinal microbiota and its effects on the immune system. Cell Microbiol, <b>16<\/b>:1004-1013, 2014.","DOI":"10.1111\/cmi.12301"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41.  Scher JU, Sczesnak A, Longman RS, <i>et al.<\/i> Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife, <b>2<\/b>:e01202, 2013","DOI":"10.7554\/eLife.01202"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42.  Kalinkovich A, Gabdulina G, Livshits G. Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis. Immunol Res, <b>66<\/b>:696-709, 2018.","DOI":"10.1007\/s12026-018-9048-x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43.  Bodkhe R, Balakrishnan B, Taneja V. The role of microbiome in rheumatoid arthritis treatment. Ther Adv Musculoskelet Dis, <b>11<\/b>:  1759720X19844632, 2019.","DOI":"10.1177\/1759720X19844632"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44.  Koga T, Migita K, Kawakami A. Biologic therapy in familial Mediterranean fever. Mod Rheumatol, <b>26<\/b>:637-641, 2016.","DOI":"10.3109\/14397595.2016.1162261"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/66\/3\/66_2020-07\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T03:47:23Z","timestamp":1607744843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/66\/3\/66_2020-07\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.2020-07","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}